When the war in Ukraine ends, Moscow will need to be part of the new security architecture, argues Andrey Melnichenko | World ...
Opus Genetics, Inc. (Nasdaq: IRD) (the "Company”, "Opus Genetics” or "Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...